David Irvine, MBChB, PhD, is a Consultant Hematologist working at the Hematopoietic Stem Cell Transplantation Unit in the Queen Elizabeth University Hospital in Glasgow in the UK. Dr Irvine has a Bachelor of Science (BSc), a Bachelor of Medicine and Bachelor of Surgery (MBChB) from the University of Glasgow (1993-2000), as well as a PhD from the same institution (2008-2011).
Dr Irvine was a clinical fellow of acute leukemia and stem cell transplantation at the British Columbia Cancer Agency in Canada from 2005 to 2006. He then joined the University of Glasgow as a clinical research training fellow (2008 – 2012) and as a clinical lecturer (2012-2014).
Speaking on leukemia and cell therapies
Dr Irvine is interested in leukemia, specifically chronic myeloid leukemia, cell therapies and transplant. His research focuses on the analysis of stem cells, gene expression alterations and novel therapeutic targets for the treatment of chronic myeloid leukemia. Dr Irvine seeks to contribute to translating cellular therapies into clinical practice.